A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients
- 1 March 1995
- journal article
- clinical trial
- Published by Springer Nature in Archiv Fur Psychiatrie Und Nervenkrankheiten
- Vol. 245 (1) , 45-49
- https://doi.org/10.1007/bf02191543
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clozapine's effect on negative symptoms in treatment-refractory schizophrenicsComprehensive Psychiatry, 1994
- Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficultiesEuropean Neuropsychopharmacology, 1993
- FACTOR ANALYSIS OF THE EXTRAPYRAMIDAL SYMPTOM RATING SCALEClinical Neuropharmacology, 1992
- Dr. Carpenter and Associates ReplyAmerican Journal of Psychiatry, 1988
- Deficit and nondeficit forms of schizophrenia: the conceptAmerican Journal of Psychiatry, 1988
- Neuroleptic-induced parkinsonism in older schizophrenicsBiological Psychiatry, 1987
- Depression, Parkinsonian Symptoms, and Negative Symptoms in Schizophrenics Treated With NeurolepticsJournal of Nervous & Mental Disease, 1987
- Effect of Pimozide on Positive and Negative Symptoms in Schizophrenic Patients: Are Negative Symptoms State Dependent?Neuropsychobiology, 1987
- Treatment of Negative SymptomsSchizophrenia Bulletin, 1985
- The Brief Psychiatric Rating ScalePsychological Reports, 1962